Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GSN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C9orf62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC146513 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ICE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYOZ3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRYL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSHR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VTA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP8L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPANXB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STPG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3C2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNMB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCGN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on